We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
05 Sep 2020 - 09 Sep 2020
Virtual Venue

Pre-Analytical Protocols Compared for Serotonin Quantification

By LabMedica International staff writers
Posted on 24 Oct 2019
Print article
Image: The VACUETTE Venous K2EDTA blood collection tubes were found the most suitable for the pre-analytical conditions for serotonin assays (Photo courtesy of Greiner Bio-One).
Image: The VACUETTE Venous K2EDTA blood collection tubes were found the most suitable for the pre-analytical conditions for serotonin assays (Photo courtesy of Greiner Bio-One).
Serotonin (5-hydroxytryptamine) is an important neurotransmitter and neuromodulator, which affects many neurophysiological processes, mood and cognition, regulates motility and sensibility in the bowel, and has an essential role in regulating blood pressure.

Since only free plasma serotonin can bind to serotonin receptors and exert biological activity, it is important to have a reliable and simple pre-analytical procedure to prepare platelet-poor plasma (PPP) for quantification of non-platelet bound serotonin. Concentrations of serotonin in PPP may vary widely due to differences in pre-analytical procedures.

Clinical scientists at the University of Bergen (Bergen, Norway) and their colleagues collected blood samples in 3 mL VACUETTE K2EDTA tubes and 5 mL VACUETTE K2EDTA gel tubes for isolation of plasma from nine healthy adults recruited at Haukeland University Hospital (Bergen, Norway) in September 2015. Six pre-analytical protocols were compared for preparation of PPP from EDTA whole blood for quantification of serotonin.

Three combinations of centrifugation with a mild centrifugation of gel-free EDTA tubes followed by a stronger centrifugation were compared to single-stage centrifugation of EDTA tubes with separator gel and heat shock treatment of blood prior to centrifugation. All samples were analyzed for serotonin using the same enzyme linked immunosorbent assay (ELISA) method.

The team reported that in one method serotonin concentrations in PPP prepared by the method of a single centrifugation at 1800 ×g at 4 ⁰C was significantly different from PPP prepared by all other methods. The scientists found that a combination of a milder first centrifugation of gel-free EDTA-tubes to separate blood cells (100 or 200×g) followed by a stronger centrifugation of the supernatant (4,500 or 14,500×g) resulted in the lowest measured serotonin concentration in PPP.

The authors concluded that two successive centrifugations to produce PPP for serotonin analysis; first a mild centrifugation to avoid mechanical stress on the platelets, and next a stronger centrifugation to remove platelets, is superior to the use of gel tubes and heat shock treatment. Their interpretation was that the first centrifugation induced little mechanical stress on the blood platelets and the second centrifugation was sufficiently strong to prevent contamination of platelets in the PPP fraction. The study was published online on September 19, 2019, in the journal Practical Laboratory Medicine.

Related Links:
University of Bergen
Haukeland University

Print article


Molecular Diagnostics

view channel
Image: Structure of the ACE2 (angiotensin-converting enzyme 2) protein (Photo courtesy of Wikimedia Commons)

Elevated Angiotensin 1–7/Angiotensin II Ratio Predicts Favorable Outcomes in Patients with Heart Failure with Potential Link to COVID-19 Patients

A high ratio of angiotensin 1-7 to angiotensin II (Ang 1–7/Ang II ratio), was found to be an independent and incremental predictor of beneficial outcomes, higher survival rate, and decreased hospitalization... Read more

Industry News

view channel
Image: ChemWell RPR Analyzer (Photo courtesy of Awareness Technology, Inc.)

Awareness Technology Announces ChemWell RPR Analyzer - The Most Significant Innovation in Syphilis Testing in Last 30 Years

Awareness Technology, Inc. (Palm City, FL, USA) has announced the most significant innovation in syphilis testing in the last 30 years with the launch of the ChemWell RPR automated nontreponemal analyzer... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.